EMA Considers Fast-Tracking Rhythm’s Insatiable Hunger & Obesity Disorders Drug

 
• By Neena Brizmohun
  
Obese
Setmelanotide is designed to target rare genetic disorders of obesity • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography